arrow
H

Himanshu Nagar

Memorial Sloan Kettering Cancer Center
H指数:19
被引数:1,154

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Interpretable machine learning identifies health system levers for survival outcomes of patients with prostate cancer

可解释机器学习识别影响前列腺癌患者生存结果的健康系统杠杆

2026-10-020
PRE
Re: Alexander Light, Max Peters, Archana Gopalakrishnan, et al. Oncological Outcomes Following Focal HIFU and Cryotherapy for Treatment of Nonmetastatic Prostate Cancer in the United Kingdom: An Updated Analysis of 3477 Patients from the Prospective HEAT and ICE Registries. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.05.007

亚历山大·莱特,马克斯·彼得斯,阿查娜·戈帕拉克里什南等人。英国非转移性前列腺癌经聚焦高强度聚焦超声和冷冻疗法治疗的肿瘤学结局:来自前瞻性HEAT和ICE登记研究的3477例患者更新分析。欧洲泌尿学杂志。待发表。http://dx.doi.org/10.1016/j.eururo.2026.05.007

2026-09-230
PRE
Daily adaptive 1.5 T MR-Linac image-guided re-irradiation for prostate cancer: an international retrospective experience

每日适应性1.5 T MR-Linac图像引导再程放疗治疗前列腺癌:一项国际回顾性经验

2026-09-110
OAAI
PrecisionPro Fusion: Clinical validation of an automated, rigid, Prostate-Specific MRI-CT Fusion system for prostate radiotherapy planning

PrecisionPro Fusion:用于前列腺放疗计划中自动化、刚性、前列腺特异性MRI-CT融合系统的临床验证

2025-11-010
OA
Radiotherapy- Versus Surgery-based Treatment Strategy in High-risk Prostate Cancer

放疗与手术为基础的治疗策略在高风险前列腺癌中的比较

2025-07-190
PRE
The Burden of Genitourinary Malignancies in Southeast Asia from 1990 to 2021

1990年至2021年东南亚泌尿生殖系统恶性肿瘤的负担

2025-05-010
PRE
Intensifying Salvage Therapy in Prostate-specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy with Apalutamide, Salvage Radiation, and Docetaxel: The Phase 2 STARTAR Trial

在根治性前列腺切除术后前列腺特异性抗原复发性前列腺癌中应用阿帕卢他胺、挽救性放疗和多西他赛强化挽救治疗:STARTAR II期临床试验

2024-07-010
PRE